CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-17 | Bitterman Kevin Director | Sale | −213 | $91.47 | $19K | 337,485 |
| 2025-12-17 | Bitterman Kevin Director | Sale | −148 | $91.47 | $14K | 14,013 |
| 2025-12-16 | Bitterman Kevin Director | Sale | −35,898 | $91.24 | $3.3M | 349,603 |
| 2025-12-16 | Bitterman Kevin Director | Sale | −18,666 | $91.24 | $1.7M | 337,698 |
| 2025-12-16 | Bitterman Kevin Director | Sale | −14,359 | $91.24 | $1.3M | 14,161 |
| 2025-12-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −3,642 | $90.60 | $330K | 85,153 |
| 2025-12-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −9,151 | $91.44 | $837K | 76,002 |
| 2025-12-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −300 | $92.23 | $28K | 75,702 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −28,913 | $91.18 | $2.6M | 389,422 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −3,921 | $92.01 | $361K | 385,501 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −14,811 | $91.18 | $1.4M | 358,413 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −2,049 | $92.01 | $189K | 356,364 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −11,427 | $91.18 | $1.0M | 30,092 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −1,572 | $92.01 | $145K | 28,520 |
| 2025-12-15 | Bitterman Kevin Director | Option exercise | +7,000 | $13.50 | $95K | 7,000 |
| 2025-12-15 | Bitterman Kevin Director | Sale | −7,000 | $91.87 | $643K | 0 |
| 2025-12-15 | Bitterman Kevin Director | Option exercise · Stock Option (Right to Buy) | −7,000 | 0 | ||
| 2025-12-12 | Bitterman Kevin Director | Sale | −16,403 | $92.05 | $1.5M | 425,633 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −3,852 | $92.58 | $357K | 421,781 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −3,446 | $93.80 | $323K | 418,335 |
Page 8 of 17 · 337 trades